Scot Middleton Selected Research

Scot Middleton Research Topics

6	Arthritis (Polyarthritis) 01/2011 - 05/2005
4	Inflammation (Inflammations) 03/2009 - 05/2005
4	Experimental Arthritis 01/2009 - 05/2005
2	Rheumatoid Arthritis 01/2011 - 05/2005
2	Leukocytosis (Pleocytosis) 03/2009 - 11/2008
2	Disease Progression 03/2009 - 11/2008
1	Hypersensitivity (Allergy) 02/2011
1	Hyperplasia 03/2009
1	Bone Resorption 01/2009
1	Metabolic Bone Diseases (Osteopenia) 10/2005

4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009 - 05/2005
3	Biomarkers (Surrogate Marker)IBA 03/2009 - 10/2005
3	OsteoprotegerinIBA 01/2009 - 05/2005
2	CollagenIBA 01/2011 - 10/2005
2	LigandsIBA 03/2009 - 01/2009
2	Interleukin-6 (Interleukin 6)IBA 03/2009 - 11/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 03/2009 - 11/2008
2	Proteins (Proteins, Gene)FDA Link 03/2009 - 11/2008
2	ProstaglandinsIBA 03/2009 - 11/2008
2	CytokinesIBA 01/2009 - 05/2005
1	AntigensIBA 02/2011
1	InterleukinsIBA 03/2009
1	Interleukin-17 (Interleukin 17)IBA 03/2009
1	Interleukin-18 (Interleukin 18)IBA 03/2009
1	Glycoproteins (Glycoprotein)IBA 03/2009
1	AcidsIBA 03/2009
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2009
1	Dinoprostone (PGE2)FDA Link 01/2009
1	Orosomucoid (Seromucoid)IBA 01/2009
1	Tartrate-Resistant Acid PhosphataseIBA 01/2009
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2009
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2009
1	Prostaglandins EIBA 11/2008
1	Cathepsin KIBA 10/2005
1	CarrageenanIBA 10/2005
1	RANK LigandIBA 10/2005
1	pyridazineIBA 05/2005
1	Mitogen-Activated Protein KinasesIBA 05/2005
1	Tumor Necrosis Factor InhibitorsIBA 05/2005
1	PEGylated soluble tumor necrosis factor receptor IIBA 05/2005
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2005
1	Parathyroid Hormone (Parathormone)IBA 05/2005
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2005
1	Type I Tumor Necrosis Factor ReceptorsIBA 05/2005

2	Therapeutics 01/2009 - 10/2005